Publications by authors named "Frances Priddy"

Claim this Profile
S
Safety and immunogenicity of an mRNA-1273 vaccine booster in adolescents.
Amparo L Figueroa, Kashif Ali, Gary Berman, Wenqin Xu, Weiping Deng, Frances Priddy

Hum Vaccin Immunother· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunogenicity of JN.1- and KP.2-Encoding mRNA COVID-19 Vaccines Against JN.1 Subvariants in Adult Participants.
Amparo L Figueroa, Bethany Girard, Darin K Edwards, Arshan Nasir, Kimball Johnson, Frances Priddy

Open Forum Infect Dis· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Test-Negative Design for Immune Correlates Approximates a Traditional Exposure Proximal Design but Requires Far Fewer Blood Samples.
Dean Follmann, Lauren Dang, Eric Chu, Jonathan Fintzi, Holly Janes, Frances Priddy

J Infect Dis· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Validating and leveraging non-SARS-CoV-2 respiratory infection as a negative control outcome in a phase 3 COVID-19 vaccine trial with extended observational follow-up.
Ethan Ashby, Holly Janes, Dean Follmann, Peter B Gilbert, Honghong Zhou, Frances Priddy

Am J Epidemiol· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immune correlates analysis of mRNA-1345 RSV vaccine efficacy clinical trial.
Chong Ma, Jiejun Du, Lan Lan, Archana Kapoor, Gonzalo Perez Marc, Frances Priddy

Nat Commun· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety, Tolerability, and Immunogenicity of mRNA-1345 in Adults at Increased Risk for RSV Disease Aged 18 to 59 Years.
Erick F Mayer, Ann R Falsey, Rebecca Clark, Murdo Ferguson, Jose Cardona, Frances Priddy

Clin Infect Dis· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluating the Test-Negative Design for COVID-19 Vaccine Effectiveness Using Randomized Trial Data: A Secondary Cross-Protocol Analysis of 5 Randomized Clinical Trials.
Leah I B Andrews, M Elizabeth Halloran, Kathleen M Neuzil, Lars van der Laan, Yunda Huang, Frances Priddy

JAMA Netw Open· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
mRNA-1273 COVID-19 vaccine induces CD4+ T-cell responses among solid organ transplant recipients.
Bethany Girard, Amparo L Figueroa, Stephen C De Rosa, M Juliana McElrath, Jamil R Azzi, Frances Priddy

Front Immunol· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and immunogenicity of a single-dose omicron-containing COVID-19 vaccination in adolescents: an open-label, single-arm, phase 2/3 trial.
Amparo L Figueroa, Dania Torres, Celia Reyes-Acuna, Paul Matherne, Anne Yeakey, Frances Priddy

Lancet Infect Dis· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association Between SARS-CoV-2 Viral Load and COVID-19 Vaccination in 4 Phase 3 Trials.
Holly Janes, Leigh H Fisher, Jia Jin Kee, Lalitha Parameswaran, Paul A Goepfert, Frances H Priddy

J Infect Dis· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
Who to Boost When: The Effect of Age and Dosing Interval on Delta and Omicron COVID-19 Incidence in the Open-label Phase of the COVE Trial.
Dean Follmann, Xiaowei Wang, Lindsey R Baden, Hana M El Sahly, Brandon Essink, Frances Priddy

Open Forum Infect Dis· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Humoral Immunogenicity of mRNA-1345 RSV Vaccine in Older Adults.
Jaya Goswami, Abdullah H Baqui, Pablo A Doreski, Gonzalo Perez Marc, Gilberto Jimenez, Frances Priddy

J Infect Dis· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and Immunogenicity of the mRNA-1273 Coronavirus Disease 2019 Vaccine in Solid Organ Transplant Recipients.
Amparo L Figueroa, Jamil R Azzi, Bijan Eghtesad, Frances Priddy, Dina Stolman

J Infect Dis· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A review of the immunogenicity and safety of booster doses of omicron variant-containing mRNA-1273 COVID-19 vaccines in adults and children.
Frances Priddy, Spyros Chalkias, Brandon Essink, Jordan Whatley, Adam Brosz

Expert Rev Vaccines· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Omicron COVID-19 immune correlates analysis of a third dose of mRNA-1273 in the COVE trial.
Bo Zhang, Youyi Fong, Jonathan Fintzi, Eric Chu, Holly E Janes, Frances Priddy

Nat Commun· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and durability of mRNA-1273-induced SARS-CoV-2 immune responses in adolescents: results from the phase 2/3 TeenCOVE trial.
Amparo L Figueroa, Kashif Ali, Gary Berman, Honghong Zhou, Weiping Deng, Frances Priddy

EClinicalMedicine· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term safety and effectiveness of mRNA-1273 vaccine in adults: COVE trial open-label and booster phases.
Lindsey R Baden, Hana M El Sahly, Brandon Essink, Dean Follmann, Gregory Hachigian, Frances Priddy

Nat Commun· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Interim safety and immunogenicity of COVID-19 omicron BA.1 variant-containing vaccine in children in the USA: an open-label non-randomised phase 3 trial.
Avika Dixit, Richard Bennett, Kashif Ali, Carl Griffin, Robert A Clifford, Frances Priddy

Lancet Infect Dis· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Robust immunogenicity of a third BNT162b2 vaccination against SARS-CoV-2 Omicron variant in a naïve New Zealand cohort.
Brittany Lavender, Caitlin Hooker, Chris Frampton, Michael Williams, Simon Carson, Frances H Priddy

Vaccine· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Monitoring of Adverse Events in Recipients of the 2-Dose Ebola Vaccine Regimen of Ad26.ZEBOV Followed by MVA-BN-Filo in the UMURINZI Ebola Vaccination Campaign.
Julien Nyombayire, Rosine Ingabire, Ben Magod, Amelia Mazzei, Jean-Baptiste Mazarati, Frances Priddy

J Infect Dis· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunogenicity of BNT162b2 COVID-19 vaccine in New Zealand adults.
Frances H Priddy, Michael Williams, Simon Carson, Brittany Lavender, Julia Mathieson

Vaccine· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety, reactogenicity, and immunogenicity of a 2-dose Ebola vaccine regimen of Ad26.ZEBOV followed by MVA-BN-Filo in healthy adult pregnant women: study protocol for a phase 3 open-label randomized controlled trial.
Etienne Karita, Julien Nyombayire, Rosine Ingabire, Amelia Mazzei, Tyronza Sharkey, Frances Priddy

Trials· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety, pharmacokinetics and antiviral activity of PGT121, a broadly neutralizing monoclonal antibody against HIV-1: a randomized, placebo-controlled, phase 1 clinical trial.
Kathryn E Stephenson, Boris Julg, C Sabrina Tan, Rebecca Zash, Stephen R Walsh, Frances H Priddy

Nat Med· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development and deployment of COVID-19 vaccines for those most vulnerable.
Wayne C Koff, Theodore Schenkelberg, Tere Williams, Ralph S Baric, Adrian McDermott, Frances H Priddy

Sci Transl Med· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Acceptability and tolerability of repeated intramuscular electroporation of Multi-antigenic HIV (HIVMAG) DNA vaccine among healthy African participants in a phase 1 randomized controlled trial.
Juliet Mpendo, Gaudensia Mutua, Annet Nanvubya, Omu Anzala, Julien Nyombayire, Frances Priddy

PLoS One· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis